https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1053/jhep.2001.22172

A model to predict survival in patients with end‐stage liver disease

https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1053/jhep.2003.50346

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.21178

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

/pdf/nccn-clinical-practice-guidelines-in-oncology-hepatobiliary-1kpacqqvi8.pdf

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

https://www.gastrojournal.org/article/S0016-5085(03)50022-1/pdf

Model for end-stage liver disease (MELD) and allocation of donor livers

https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1053/he.2000.5852

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.

PURPOSE: In the setting of hepatic failure and portal hypertension, hemorrhage from stomal and rectal varices is a well-described problem It has recently been suggested that transjugular intrahepatic portosystemic shunting may be useful in the therapy of bleeding from parastomal or anorectal varices in patients unresponsive to conservative therapy METHODS: We retrospectively review our institution's experience of five patients with parastomal varices and seven patients with anorectal varices who underwent transjugular intrahepatic portosystemic shunting for hemorrhage refractory to conservative management between 1994 and 1998 RESULTS: The study group consisted of four Child's A, five Child's B, and three Child's C patients The mean age of the patients was 603 (range, 37–85) years Mean follow-up was 15 (range, 5–27) months The mean portosystemic pressure gradient before transjugular intrahepatic portosystemic shunting was 174±31 mmHg After transjugular intrahepatic portosystemic shunting, the mean portosystemic pressure gradient was reduced to 58±18 mmHg (P<005) Transjugular intrahepatic portosystemic shunting were successful in complete resolution of bleeding in all patients Three patients had encephalopathic changes after transjugular intrahepatic portosystemic shunting Two patients died within 30 days of transjugular intrahepatic portosystemic shunting of causes unrelated to the procedure Four patients required shunt revision within one year of placement CONCLUSION: The transjugular intrahepatic portosystemic shunting procedure is an effective modality in the therapy of cirrhotic patients with bleeding stomal or anorectal varices unresponsive to conservative management There is an acceptable procedure-related morbidity and mortality

https://rd.springer.com/content/pdf/10.1007%2FBF02236211.pdf

Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension

Combined liver‐kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross‐match and benefits of combined transplantation

Fredric D. Gordon

Papers

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.

Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension

Combined liver‐kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross‐match and benefits of combined transplantation

Fibrosis/cirrhosis after orthotopic liver transplantation